Aurora Cannabis CEO Miguel Martin thinks the cannabis industry and its investors are too focused on US recreational consumers and are missing a more profitable opportunity: medical marijuana.

Aurora Cannabis (ACB) is pleased to announce the company’s discovery of a novel source of genetic resistance against powdery mildew, PM2, that ...

Aurora Cannabis has transformed its margins, market position, and balance sheet over the last few years, and the stock is now highly 'investible'. ACB's strategic focus on the global medical ...

Medical cannabis pastilles offer benefits, including an oral intake. Pastilles also come in an accessible format. EDMONTON — Aurora Cannabis extends pastille offerings in Australia.

The year is a more than a month old, but Aurora Cannabis (NASDAQ: ACB) is already one of the hottest stocks to own in 2025. As of Feb. 11, the pot stock has soared more than 50% since the year ...

Shares of Aurora Cannabis Inc. ACB rallied 5.30% to $4.57 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.33% to ...

The stock's fall snapped a two-day winning streak.

Has Aurora Cannabis Inc. (ACB) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer ...